The expression levels of Cav-1, ROCK1 and Parkin in lung cancer cells treated with cisplatin are increased, and Cav-1 knockdown can inhibit ROCK1, downregulate Parkin related mitophagy. The gene discussed is PRKN; the disease is lung carcinoma.